These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28318310)

  • 1. Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.
    Schlusser KE; Konikoff J; Kirkpatrick AR; Morrison C; Chipato T; Chen PL; Munjoma M; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):555-557. PubMed ID: 28318310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
    Sempa JB; Welte A; Busch MP; Hall J; Hampton D; Facente SN; Keating SM; Marson K; Parkin N; Pilcher CD; Murphy G; Grebe E;
    PLoS One; 2019; 14(7):e0220345. PubMed ID: 31348809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.
    Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C;
    PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
    Keating SM; Rountree W; Grebe E; Pappas AL; Stone M; Hampton D; Todd CA; Poniewierski MS; Sanchez A; Porth CG; Denny TN; Busch MP;
    PLoS One; 2019; 14(9):e0222290. PubMed ID: 31525218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
    Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short Communication: Heightened HIV Antibody Responses in Postpartum Women as Exemplified by Recent Infection Assays: Implications for Incidence Estimates.
    Hargrove JW; van Schalkwyk C; Humphrey JH; Mutasa K; Ntozini R; Owen SM; Masciotra S; Parekh BS; Duong YT; Dobbs T; Kilmarx PH; Gonese E
    AIDS Res Hum Retroviruses; 2017 Sep; 33(9):902-904. PubMed ID: 28443672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.
    Laeyendecker O; Konikoff J; Morrison DE; Brookmeyer R; Wang J; Celum C; Morrison CS; Abdool Karim Q; Pettifor AE; Eshleman SH
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29489059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of HIV Incidence in the Zimbabwe Population-Based HIV Impact Assessment Survey (2015-2016) with Modeled Estimates: Progress Toward Epidemic Control.
    Gonese E; Musuka G; Ruangtragool L; Hakim A; Parekh B; Dobbs T; Duong YT; Patel H; Mhangara M; Mugurungi O; Mapingure M; Saito S; Herman-Roloff A; Gwanzura L; Tippett-Barr B; Kilmarx PH; Justman J
    AIDS Res Hum Retroviruses; 2020 Aug; 36(8):656-662. PubMed ID: 32498542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China.
    Yu L; Laeyendecker O; Wendel SK; Liang F; Liu W; Wang X; Wang L; Pang X; Fang Z
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1247-9. PubMed ID: 26331573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
    Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
    Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.
    Schlusser KE; Pilcher C; Kallas EG; Santos BR; Deeks SG; Facente S; Keating SM; Busch MP; Murphy G; Welte A; Quinn T; Eshleman SH; Laeyendecker O
    PLoS One; 2017; 12(2):e0172283. PubMed ID: 28231277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.
    Grebe E; Welte A; Hall J; Keating SM; Facente SN; Marson K; Martin JN; Little SJ; Price MA; Kallas EG; Busch MP; Pilcher CD; Murphy G
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):547-555. PubMed ID: 28914669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
    Duong YT; Kassanjee R; Welte A; Morgan M; De A; Dobbs T; Rottinghaus E; Nkengasong J; Curlin ME; Kittinunvorakoon C; Raengsakulrach B; Martin M; Choopanya K; Vanichseni S; Jiang Y; Qiu M; Yu H; Hao Y; Shah N; Le LV; Kim AA; Nguyen TA; Ampofo W; Parekh BS
    PLoS One; 2015; 10(2):e0114947. PubMed ID: 25710171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an HIV recent infection testing algorithm with serological assays among men who have sex with men in Mexico.
    Karatzas-Delgado EF; Ruiz-González V; García-Cisneros S; Olamendi-Portugal ML; Herrera-Ortiz A; López-Gatell H; González-Rodríguez A; Sánchez-Alemán MA
    J Infect Public Health; 2020 Apr; 13(4):509-513. PubMed ID: 31813835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.
    Lynch BA; Patel EU; Courtney CR; Nanfack AJ; Bimela J; Wang X; Eid I; Quinn TC; Laeyendecker O; Nyambi PN; Duerr R; Redd AD
    AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1114-1116. PubMed ID: 28670965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.